Cases & Deals

  • Home
  • Practices
  • Astellas enters into collaboration and exclusive license agreement with Generian

Share

Astellas enters into collaboration and exclusive license agreement with Generian

June 2022

Client(s) Astellas Pharma Inc.

Jones Day advised Astellas Pharma Inc. and its affiliate Mitobridge, Inc. in connection with a collaboration and exclusive license agreement with Generian Pharmaceuticals, Inc. to discover and develop novel small molecules for undruggable therapeutic targets.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.